Titan Pharmaceuticals

Titan Pharmaceuticals, Inc. is a development-stage biotechnology company dedicated to developing proprietary therapeutics using its clinically proven ProNeura long-term, continuous drug delivery technology. Our mission is to provide innovative solutions for treating chronic conditions by ensuring consistent, around-the-clock blood levels of medication. This approach aims to improve patient outcomes and enhance medical results.

Our ProNeura Technology

ProNeura consists of a small, semi-rigid, flexible implant made from a mixture of EVA (ethylene-vinyl acetate) and a drug substance. This resulting product is a solid matrix implant that is placed subcutaneously, typically in the inner part of the upper arm, in a simple office procedure and is removed in a similar manner at the end of the treatment period. These procedures can be performed by trained healthcare providers, including licensed and surgically qualified physicians, nurse practitioners, and physician's assistants in a healthcare provider's office or other clinical setting.

Our Product Pipeline

We are committed to advancing the treatment of select chronic diseases through our innovative products. Our current pipeline includes:

• Kappa Opioid Receptor Agonist (TP-2021) Implant: This product is designed for the treatment of moderate-to-severe chronic pruritus. By delivering a low dose of medication continuously over an extended period, we aim to provide relief from this debilitating condition.

• Nalmefene Implant: This implant is intended for the prevention of relapse in opioid use disorder (OUD) patients following detoxification from opioids. By maintaining stable blood levels of nalmefene, we believe this product can significantly reduce the risk of relapse and improve treatment outcomes for individuals struggling with opioid addiction.

Our Expertise and Leadership

Our team comprises experienced professionals with a deep understanding of drug development, regulatory affairs, and commercialization strategies. Our board of directors and management team are committed to guiding the company towards achieving its goals and creating value for our stakeholders.

Career Opportunities

We are always looking for talented individuals who share our passion for improving patient lives through innovative drug delivery technologies. If you are interested in joining our team, please visit our careers section for available positions and application instructions.

Investor Relations

As a publicly traded company, we are committed to providing transparent and timely information to our investors. Our investor relations section offers access to our latest news, events, company information, stock data, SEC filings, and corporate governance practices.

At Titan Pharmaceuticals, we are dedicated to advancing the treatment of chronic diseases through our innovative ProNeura technology. We believe that our products have the potential to significantly improve patient outcomes and enhance medical results. As we continue to develop and commercialize our proprietary therapeutics, we remain committed to our mission of improving lives through innovative medicine.